Skip to main content

Enliven Therapeutics, Inc. insider trading

ELVNNASDAQ
$46.97+0.76 (+1.64%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+135.8%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flow

Key players

  • SKSamuel KintzPRESIDENT AND CEO1.2152%of company
  • JPJoseph P. LyssikatosCHIEF SCIENTIFIC OFFICER1.0358%of company
  • APAnish PatelCHIEF OPERATING OFFICER0.3207%of company
  • RARichard A. HeymanDirector0.2346%of company
  • LALori Anne KunkelDirector0.0572%of company
  • BHBenjamin HohlCHIEF FINANCIAL OFFICER0.0519%of company
  • HLHelen Louise CollinsCHIEF MEDICAL OFFICER0.0341%of company
  • RDRahul D. BallalDirector0.0305%of company
  • MKMika K. DerynckDirector0.00%of company
  • OAOrbimed Advisors LLC10% OwnerNot reportedof company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
ELVNBenjamin HohlCHIEF FINANCIAL OFFICEROpen market sell$82.4K-3.4%$59.35$82.4KAug 17, 2026Aug 19, 2026
ELVNBenjamin HohlCHIEF FINANCIAL OFFICEROpen market sell$270K-10.1%$58.35$270KAug 17, 2026Aug 19, 2026
ELVNLori Anne KunkelDirectorOpen market sell$299K-12.3%$50.84$299KJul 6, 2026Jul 8, 2026
ELVNLori Anne KunkelDirectorOpen market sell$205K-7.9%$49.98$205KJul 6, 2026Jul 8, 2026
ELVNOrbimed Advisors LLC10% OwnerOpen market sell$2.1M-0.7%$45.00$2.1MJun 22, 2026Jun 24, 2026
ELVNOrbimed Advisors LLC10% OwnerOpen market sell$35.7M-10.7%$45.38$35.7MJun 22, 2026Jun 24, 2026
ELVNOrbimed Advisors LLC10% OwnerOpen market sell$66.5K-0.7%$45.00$66.5KJun 22, 2026Jun 24, 2026
ELVNOrbimed Advisors LLC10% OwnerOpen market sell$1.13M-10.1%$45.38$1.13MJun 22, 2026Jun 24, 2026
ELVNOrbimed Advisors LLC10% OwnerOpen market sell$12.3M-3.6%$45.02$12.3MJun 15, 2026Jun 17, 2026
ELVNOrbimed Advisors LLC10% OwnerOpen market sell$409K-3.6%$45.02$409KJun 15, 2026Jun 17, 2026
ELVNLori Anne KunkelDirectorOpen market sell$12.7K-0.7%$35.82$12.7KJun 5, 2026Jun 9, 2026
ELVNLori Anne KunkelDirectorOpen market sell$66K-3.5%$35.36$66KJun 5, 2026Jun 9, 2026
ELVNLori Anne KunkelDirectorOpen market sell$267K-12.6%$34.28$267KJun 5, 2026Jun 9, 2026
ELVNBenjamin HohlCHIEF FINANCIAL OFFICEROpen market sell$296K-16.4%$29.58$296KMar 6, 2026Mar 10, 2026
ELVNRichard A. HeymanDirectorOpen market sell$32.2K-0.8%$26.18$32.2KFeb 17, 2026Feb 19, 2026
ELVNJoseph P. LyssikatosCHIEF SCIENTIFIC OFFICEROpen market sell$145K-0.7%$29.04$145KFeb 6, 2026Feb 10, 2026
ELVNJoseph P. LyssikatosCHIEF SCIENTIFIC OFFICEROpen market sell$390K-1.9%$26.90$390KJan 20, 2026Jan 22, 2026
ELVNJoseph P. LyssikatosCHIEF SCIENTIFIC OFFICEROpen market sell$145K-0.7%$26.37$145KJan 20, 2026Jan 22, 2026
ELVNRichard A. HeymanDirectorOpen market sell$19.4K-0.5%$26.96$19.4KJan 20, 2026Jan 22, 2026
ELVNRichard A. HeymanDirectorOpen market sell$13.5K-0.3%$26.46$13.5KJan 20, 2026Jan 22, 2026
ELVNAnish PatelCHIEF OPERATING OFFICEROpen market sell$6.93K-0.1%$28.50$6.93KJan 9, 2026Jan 13, 2026
ELVNAnish PatelCHIEF OPERATING OFFICEROpen market sell$1.34M-18.3%$27.98$1.34MJan 9, 2026Jan 13, 2026
ELVNJoseph P. LyssikatosCHIEF SCIENTIFIC OFFICEROpen market sell$1.46M-6.1%$29.13$1.46MJan 9, 2026Jan 12, 2026
ELVNJoseph P. LyssikatosCHIEF SCIENTIFIC OFFICEROpen market sell$1.03M-4.8%$24.90$1.03MJan 9, 2026Jan 12, 2026
ELVNRichard A. HeymanDirectorOpen market sell$107K-2.8%$25.00$107KJan 9, 2026Jan 12, 2026
ELVNJoseph P. LyssikatosCHIEF SCIENTIFIC OFFICEROpen market sell$842K-3.8%$24.92$842KJan 8, 2026Jan 12, 2026
ELVNJoseph P. LyssikatosCHIEF SCIENTIFIC OFFICEROpen market sell$151K-0.8%$20.13$151KJan 8, 2026Jan 12, 2026
ELVNRichard A. HeymanDirectorOpen market sell$201K-5.0%$25.04$201KJan 8, 2026Jan 12, 2026
ELVNRichard A. HeymanDirectorOpen market sell$40.5K-1.1%$25.00$40.5KJan 8, 2026Jan 12, 2026
ELVNJoseph P. LyssikatosCHIEF SCIENTIFIC OFFICEROpen market sell$84.2K-0.6%$16.84$84.2KDec 19, 2025Dec 23, 2025
ELVNAnish PatelCHIEF OPERATING OFFICEROpen market sell$37.1K-0.6%$21.78$37.1KDec 8, 2025Dec 10, 2025
ELVNAnish PatelCHIEF OPERATING OFFICEROpen market sell$103K-1.8%$20.76$103KDec 8, 2025Dec 10, 2025
ELVNJoseph P. LyssikatosCHIEF SCIENTIFIC OFFICEROpen market sell$11.4K-0.1%$23.09$11.4KNov 19, 2025Nov 21, 2025
ELVNJoseph P. LyssikatosCHIEF SCIENTIFIC OFFICEROpen market sell$268K-1.3%$22.30$268KNov 19, 2025Nov 21, 2025
ELVNSamuel KintzPRESIDENT AND CEOOpen market sell$273K-1.4%$21.82$273KNov 17, 2025Nov 19, 2025
ELVNAnish PatelCHIEF OPERATING OFFICEROpen market sell$11K-0.2%$17.94$11KNov 7, 2025Nov 12, 2025
ELVNAnish PatelCHIEF OPERATING OFFICEROpen market sell$105K-2.2%$17.35$105KNov 7, 2025Nov 12, 2025
ELVNJoseph P. LyssikatosCHIEF SCIENTIFIC OFFICEROpen market sell$276K-1.4%$22.08$276KOct 20, 2025Oct 22, 2025
ELVNSamuel KintzPRESIDENT AND CEOOpen market sell$267K-1.4%$21.33$267KOct 17, 2025Oct 21, 2025
ELVNAnish PatelCHIEF OPERATING OFFICEROpen market sell$134K-2.4%$20.10$134KOct 7, 2025Oct 9, 2025
End of history · 40 transactions

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.